Essential thrombocythemia (ET): the blood with too many platelets
Last updated September 3, 2026.
Essential thrombocythemia (ET) is the slow-growing blood disorder (the myeloproliferative neoplasm: the bone marrow making too many platelets), usually found by the accident on the routine blood count, mostly in the middle-aged-and-older adults. Most people with it live the normal-length lives with the condition managed (the low-dose aspirin for many, the count-lowering medicines for the higher-risk), and the risks it carries (the clots, the bleeding paradoxically, the rare progression) are what the monitoring-and-treatment exist to prevent.
What are the symptoms?
Often none (the incidental finding). When present: the headaches, the dizziness, the visual disturbances, the burning-or-tingling in the hands-and-feet (the erythromelalgia: the red hot burning feet, relieved by the cooling), the unusual clotting (the deep-vein clots, the strokes, the clots in the unusual places like the abdomen), and paradoxically the bleeding (the very high platelets can interfere with the clotting: the nosebleeds, the bruising, the gum bleeding).
Why does it happen?
The acquired gene mutation in the blood stem cells (the JAK2, the CALR, or the MPL in the most: the random event, not inherited, not lifestyle-caused), driving the platelet overproduction. The diagnosis needs the excluding of the reactive causes (the iron deficiency, the inflammation, the infection, the post-surgery: the common reasons for the high platelets that are not the ET), which is why the one high reading starts the conversation, not the conclusion.
How is it managed?
- The risk-stratified approach: the low-risk (the young, the no-clot-history, the lower counts): the low-dose aspirin alone or the watching; the higher-risk (the over-60s, the previous clots, the very high counts): the count-lowering medicines (the hydroxyurea commonly, the anagrelide, the interferon).
- The clot-prevention: the low-dose aspirin for the most (the microvascular symptoms often melt on it: the burning-feet kind especially), and the cardiovascular risks managed (the smoking, the pressure, the cholesterol: compounding the clot risk).
- The monitoring: the regular blood counts and the hematology follow-up (the progression to the marrow scarring or the leukemia is the small-percentage long-term risk: watched, not expected).
- The pregnancy-and-surgery planning: the special-management situations (the hematology coordinating: the ET raises the stakes in both, and the management adjusts).
When does it need the urgent care?
The 911-or-ER for the clot symptoms: the stroke signs (the face-arm-speech), the chest pain, the breathlessness (the lung clot), the leg swelling-and-pain, or the severe headache with the vision loss. The prompt contact for the unusual bleeding. Pymander's escalation routing is built and tested specifically for this class of decision; see the safety architecture working paper.
What a Pymander AI doctor consult looks like
Illustrative example, not a real member's messages.
Common questions
Is essential thrombocythemia a cancer?
The technical answer: it is classified as the blood cancer (the myeloproliferative neoplasm: the marrow overgrowing one cell line), but the behavior is what matters to you: the ET grows slowly, does not spread, does not require the chemotherapy in the usual sense, and the most with it have the near-normal life expectancy (the condition managed, like the blood pressure is managed). The classification word is scarier than the condition: the rare progression (the marrow scarring, the leukemia) is watched for over the years, and affects the small minority.
Why do I need aspirin if my platelets are high? Wouldn't more clotting be the problem?
The paradox at the center of the ET: the risk runs both ways (the too many platelets cause the clots in the small vessels: the headaches, the burning feet, and sometimes the serious clots: the aspirin thins this tendency), while the very extreme platelet counts can paradoxically cause the bleeding (the acquired-von-Willebrand effect). The aspirin suits most, the decision individualized (the bleeding history, the count level), and the burning-feet-and-headache symptoms often resolve noticeably on it.
Could my high platelets be something simpler?
Often, and that is the hematologist's first job: the reactive thrombocytosis (the platelets raised by the something else: the iron deficiency, the inflammation, the infection, the recent surgery, the post-spleen-removal) is far commoner than the ET, and it normalizes when the cause resolves. The ET diagnosis requires the persistent elevation plus the excluding of the reactive causes, usually with the mutation testing (the JAK2-CALR-MPL: found in most ET). Your two readings a month apart start that process, not finish it.
What is the long-term outlook?
The favorable kind for most: the normal-or-near-normal life expectancy (the large studies show the ET patients living as long as the matched population in the lower-risk groups), the treatment typically the simple daily medicines, and the life-normal (the work, the travel, the pregnancies manageable with the planning). The long-term risks exist (the transformation to the marrow fibrosis or the acute leukemia in the small percentages over the decades), which is what the regular monitoring is for: the watched condition, not the ticking clock.
What symptoms should make me act fast?
The clot symptoms, treated as the emergencies: the stroke signs (the face drooping, the arm weak, the speech slurred: the 911), the chest pain, the sudden breathlessness (the lung clot), the one-leg swelling-and-pain (the vein clot), and the severe sudden headache or the vision loss. The bleeding the other way (the unusual: the prolonged nosebleeds, the blood in the stool-or-urine) gets the prompt review. Between the extremes, the burning-red feet, the headaches, and the visual disturbances get reported at the next contact.
Can I get pregnant with ET?
Yes, with the planning: the pregnancy with the ET carries the raised risks (the clots, the pregnancy complications), all manageable with the hematology-obstetric joint care (the treatment adjusted: the aspirin and the heparin-kind injections used, the hydroxyurea stopped before the conception: the teratogenicity), and most women with the ET have the successful pregnancies with the right team. The key: the pregnancy planned with the hematology, not announced to it.